All Episodes

A Decade of Data: JCO PO and the TAPUR Study

JCO PO Article Insights: Breast Neuroendocrine Carcinoma Beyond Histology

cfDNA Epigenetics for Toxicity Monitoring

JCO PO Article Insights: Clinical ctDNA Testing in Advanced Pediatric Solid Tumors

ALK+ Squamous and Adenosquamous NSCLC

JCO PO Article Insights: Genomics of MTAP Loss and Co-Alteration Landscape

Immune Checkpoint Blockade in dMMR/MSI-H Advanced UTUC

JCO PO Article Insights: Dynamic Monitoring of Anti-EGFR Resistance in Metastatic Colorectal Cancer

Phase II Study of Seribantumab in Tumors Harboring NRG1 Fusions

JCO PO Article Insights: Circulating Cancer Genome Atlas Study 5-year Outcomes

JCO PO Article Insights: Analytical Validation of Tumor-Informed ctDNA Assays for MRD

Oncotype DX Breast Recurrence Score® Results from Paired CNB & SE Specimens

ctDNA in Metastatic Invasive Lobular Carcinoma

JCO PO Article Insights: Circulating Tumor DNA in Germ Cell Tumors

FGFR2b Prevalence in Advanced GC: FORTITUDE-101 Prescreening

Palbociclib in Tumors with CDKN2A Loss or Mutation

FGFR3 Alteration Status and Immunotherapy in Urothelial Cancer

JCO PO Article Insights: Genomic Risk Classifiers in Localized Prostate Cancer

DLL3 and SEZ6 Expression in Neuroendocrine Carcinomas

Somatic Mutations of Colorectal Cancer by Birth Cohort

Areas of Uncertainty in Pancreatic Cancer Surveillance

Lynch Syndrome Mortality in the Immunotherapy Era

JCO PO Article Insights: A Retrospective Analysis to Identify ICI-Sensitive Populations

Genomic Profile of Small Cell Bladder, Lung and Urothelial Cancer

JCO PO Article Insights: MUC16 Directed BiTE Therapy in Epithelioid Sarcoma

BRCA-Altered Uterine Sarcoma Treated with PARP Inhibitors

JCO PO Article Insights: Prognostic Gene Expression Signature and MYC Expression in Osteosarcoma

JCO PO Article Insights: Prognostic Gene Expression Signature and MYC Expression in Osteosarcoma

JCO PO Article Insights: Real-Time Monitoring in RCC with ctDNA

A Position Paper on ctDNA Testing in Clinical Trials

JCO PO Article Insights: TMB and Real-World ICI Outcomes in Melanoma

Effectiveness and Cost-Effectiveness of Gene Panels in Melanoma

JCO PO Article Insights: Exceptional Responders with Abexinostat and Pazopanib

Prognostic Artificial Intelligence Scores and Outcomes in Nonmetastatic Prostate Cancer

JCO PO Article Insights: Prognostic Artificial Intelligence Nonmetastatic Prostate Cancer

JCO PO Article Insights: Therapy of Infantile Midline Low-Grade Gliomas

Adagrasib Following Sotorasib-Related Hepatotoxicity

JCO PO Article Insights: ctDNA as a Prognostic Biomarker in EGC

Proteomics Predictor for Immunotherapy Benefit

Transcriptome and ctDNA Associates with Pembrolizumab Benefit

JCO PO Article Insights: Germline Pathogenic Variants in Renal Cell Carcinoma

Uptake of Aspirin Chemoprevention in Lynch Syndrome

JCO PO Article Insights: Talazoparib in Solid Tumors with BRCA1/2 Mutation

Transcriptomic Profiling of Non-Localized Prostate Cancer

JCO PO Article Insights: MCED Test Preferentially Detects High-Grade Prostate Cancers

Molecular Characteristics of Early-Onset Biliary Tract Cancer

JCO PO Article Insights: Publication Trends in JCO Precision Oncology

CCR Score to Predict ADT Benefit in Men with Prostate Cancer

JCO PO Article Insights: Statistical Considerations for Biomarker-Driven Oncology Clinical Trials

JCO PO Article Insights: Role of ctDNA in Appendiceal Cancer

PD-L1 Assay Concordance in Gastric Cancer

JCO PO Article Insights: Serial Post Operative ctDNA Predicts Poor Breast Cancer Outcome

Phase II Study of Erdafitinib in Tumors with FGFR Amplifications and Mutations or Fusions

JCO PO Article Insights: Web-Based Pretest Genetic Education for Prostate Cancer Germline Testing

Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment

JCO PO Article Insights: Microsatellite Instability as a Biomarker in Clinical Practice

Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy

JCO PO Article Insights: Prediction of Adjuvant Pertuzumab Benefit by 80-GS

MultiCancer Detection Test Performance in Symptomatic Individuals

JCO PO Article Insights: Diverse Study Samples in Clinical Trials

Tumor Mutational Burden and Advanced Pancreatic Cancer

Representativeness of Lung-MAP Participants

Perspectives on Universal Germline Testing for Colorectal Cancer

Outcomes of the IMMray PanCan-d Test in High-Risk Individuals

Implementation of the Maine Cancer Genomics Initiative

Pertuzumab + Trastuzumab in Lung Cancer with ERBB2 Alterations

MMR-P Colorectal Cancer in Lynch Syndrome

Real-World NTRK Fusions and TRK Inhibitors in Veterans

Larotrectinib for TRK Fusion - Positive Lung Cancer

ctDNA for Recurrence Prediction in Esophagogastric Cancers

KRAS Variants, G12C, TMB, high PD-L1 Expression in Solid Tumors

Universal Genetic Germline Testing in Solid Tumor Cancer Patients

Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial Carcinoma, with Dr. Shilpa Gupta

Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors, with Dr. Mark Stewart

Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures with Dr. Mark Yarchoan

Hyperthermic Intraperitoneal Chemotherapy–Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer with Dr. Thanh Dellinger

Introducing JCO Precision Oncology and Its Editor in Chief, Dr. James Ford